최형균 프로필 사진

최형균

Choi, Hyung Kyoon

약학대학

약학부

Web Of Science Scopus ORCID

자료 필터

자료유형

발행연도

2004 ~ 2026
2004 2026

키워드

언어

전체 215건 중 21번부터 30번까지의 결과를 표시합니다.

2023
Article

Metabolic Engineering for Redirecting Carbon to Enhance the Fatty Acid Content of Synechocystis sp. PCC6803

  • 유단비 ; 
  • 홍성주 ; 
  • 윤성훈 ; 
  • 강미진 ; 
  • 조병관 ; 
  • ... 최형균 ; 
  • 외 3명
  • 2023-04
  • Biotechnology and Bioprocess Engineering
  • 한국생물공학회
Article

Melatonin Treatment Enhances the Growth and Productivity of Useful Metabolites in the In Vitro Culture of Spirodela polyrhiza

  • 2023-01
  • Journal of Agricultural and Food Chemistry
  • American Chemical Society
2022
Article

Differentiation of Geographical Origin of White and Brown Rice Samples Using NMR Spectroscopy Coupled with Machine Learning Techniques

  • Saeed, M. ; 
  • Kim, J.-S. ; 
  • Kim, S.-Y. ; 
  • Ryu, J.E. ; 
  • Ko, J. ; 
  • ... Choi, H.-K. ; 
  • 외 4명
  • 2022-11
  • Metabolites
  • MDPI
Article

Development and metabolic profiling of a postbiotic complex exhibiting antibacterial activity against skin microorganisms and anti-inflammatory effect on human keratinocytes

  • Chung, H.-J. ; 
  • Lee, H. ; 
  • Kim, M. ; 
  • Lee, J.W. ; 
  • Saeed, M. ; 
  • ... Choi, H.-K. ; 
  • 외 5명
  • 2022-09
  • Food Science and Biotechnology
  • The Korean Society of Food Science and Technology
Patent

백미 또는 현미의 원산지 판별용 바이오마커 및 이를 이용한 원산지 판별방법

  • 김영석 ; 
  • 김소연 ; 
  • 김석영 ; 
  • 이도엽 ; 
  • 이보미 ; 
  • ... 최형균 ; 
  • 외 1명
  • 2022-06-02
Article

Anticancer activity and metabolic profile alterations by ortho-topolin riboside in in vitro and in vivo models of non-small cell lung cancer

  • 2022-02
  • The FASEB Journal
  • John Wiley and Sons Inc
Article

Metabolic and lipidomic characterization of radioresistant MDA-MB-231 human breast cancer cells to investigate potential therapeutic targets

  • Lee, H. ; 
  • To, N.B. ; 
  • Kim, M. ; 
  • Nguyen, Y.T.-K. ; 
  • Cho, S.K. ; 
  • ... Choi, H.-K.
  • 2022-01
  • Journal of Pharmaceutical and Biomedical Analysis
  • Elsevier B.V.